Deregulation of CircANXA2, Circ0075001, and CircFBXW7 Gene Expressions and Their Predictive Value in Egyptian Acute Myeloid Leukemia Patients

References

• Prada-Arismendy J, Arroyave JC, Rothlisberger S. Molecular biomarkers in acute myeloid leukemia. Blood Rev. 2017;31(1):63–76.
   PubMed Web of Science ®Google Scholar
• Czerw T, Labopin M, Gorin NC, et al. Long-term follow-up of patients with acute myeloid leukemia surviving and free of disease recurrence for at least 2 years after autologous stem cell transplantation: a report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. Cancer. 2016;122(12):1880–1887.
   PubMed Web of Science ®Google Scholar
• Kantarjian H, Kadia T, DiNardo C, et al. Acute myeloid leukemia: current progress and future directions. Blood Cancer J. 2021;11:41.
   PubMed Web of Science ®Google Scholar
• Wang J, Pan J, Huang S, et al. Development and validation of a novel circular RNA as an independent prognostic factor in acute myeloid leukemia. BMC Med. 2021;19(1):28. doi:10.1186/s12916-020-01898-y
   PubMed Web of Science ®Google Scholar
• Dohner H, Estey E, Grimwade D, et al. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood. 2017;129(4):424–447.
   PubMed Web of Science ®Google Scholar
• Angenendt L, Röllig C, Montesinos P, et al. Chromosomal Abnormalities and Prognosis in NPM1-Mutated Acute Myeloid Leukemia: a Pooled Analysis of Individual Patient Data from Nine International Cohorts. J Clin Oncol. 2019;37(29):2632–2642. doi:10.1200/JCO.19.00416
   PubMed Web of Science ®Google Scholar
• Richard-Carpentier G, DiNardo CD. Single-agent and combination biologics in acute myeloid leukemia. Hematol Am Soc Hematol Educ Program. 2019;1:548–556.
   Google Scholar
• Pradeep C, Nandan D, Das AA, Velayutham D. Comparative transcriptome profiling of disruptive technology, single-molecule direct RNA sequencing. Curr.Bioinf. 2020;15:165–172.
   Web of Science ®Google Scholar
• Jiao S, Wu S, Huang S, Liu M, Gao B. Advances in the Identification of Circular RNAs and Research Into circRNAs in Human Diseases. Front Genet. 2021;12:665233. doi:10.3389/fgene.2021.665233
   PubMed Web of Science ®Google Scholar
• Zhao T, Hu Y, Cheng L. Deep-DRM: a computational method for identifying disease-related metabolites based on graph deep learning approaches. Brief Bioinform. 2021;22(4):548.
   Web of Science ®Google Scholar
• Yang Y, Fan X, Mao M, et al. Extensive translation of circular RNAs driven by N6-methyladenosine. Cell Res. 2017;27(5):626–641.
   PubMed Web of Science ®Google Scholar
• Du WW, Yang W, Chen Y, et al. Foxo3 circular RNA promotes cardiac senescence by modulating multiple factors associated with stress and senescence responses. Eur Heart J. 2017;38(18):w1.
   PubMed Web of Science ®Google Scholar
• Qian L, Yu S, Chen Z, et al. The emerging role of circRNAs and their clinical significance in human cancers. Biochimica et Biophysica Acta. 2018;1870(2):247–260.
   PubMed Web of Science ®Google Scholar
• Li X, Yang L, Chen L. The biogenesis, functions, and challenges of circular RNAs. Mol Cell. 2018;71(3):428–442.
   PubMed Web of Science ®Google Scholar
• Cheng D, Wang J, Dong Z, et al. Cancer-related circular RNA: diverse biological functions. Cancer Cell Int. 2021;21:11.
   PubMed Web of Science ®Google Scholar
• Liang G, Liu Z, Tan L, et al. HIF1α-associated circDENND4C promotes proliferation of breast cancer cells in a hypoxic environment. Anticancer Res. 2017;37(8):4337–4343.
   PubMed Web of Science ®Google Scholar
• Yao Z, Luo J, Hu K, et al. ZKSCAN1 gene and its related circular RNA (circZKSCAN1) both inhibit hepatocellular carcinoma cell growth, migration, and invasion but through different signaling pathways. Mol Oncol. 2017;11(4):422–437.
   PubMed Web of Science ®Google Scholar
• Huang X, Huang Z, Xu Y, et al. Comprehensive circular RNA profiling reveals the regulatory role of the circRNA-100338/miR-141-3p pathway in hepatitis B-related hepatocellular carcinoma. Sci Rep. 2017;7(1):5428.
   PubMed Web of Science ®Google Scholar
• Bach D, Lee SK, Sood AK. Circular RNAs in cancer. Mol Ther Nucleic Acids. 2019;16:118–129.
   PubMedGoogle Scholar
• Zhang S. The characteristics of circRNA as competing endogenous RNA in the pathogenesis of acute myeloid leukemia. BMC Cancer. 2021;21(1):277. doi:10.1186/s12885-021-08029-7
   PubMed Web of Science ®Google Scholar
• Dohner H, Weisdorf DJ, Bloomfield CD. Acute Myeloid Leukemia. N Engl J Med. 2015;373(12):1136–1152.
   PubMed Web of Science ®Google Scholar
• Dohner H, Estey E, Grimwade D, et al. Diagnosis and management of AML in adult patients: 2017 ELN recommendations from an international expert panel. Blood. 2017;129:424–447.
   PubMed Web of Science ®Google Scholar
• Wiernik PH, Banks PL. Cytarabine plus idarubicin or daunorubicin as induction and consolidation therapy for previously untreated adult patients with acute myeloid leukemia. Blood. 1992;79(2):313–319.
   PubMed Web of Science ®Google Scholar
• Tallman MS, Nabhan C, Feusner JH, Rowe JM. Acute promyelocytic leukemia: evolving therapeutic strategies. Blood. 2002;99(3):759.
   PubMed Web of Science ®Google Scholar
• Sekeres MA, Lancet JE, Wood BL, et al. Randomized phase IIb study of low-dose cytarabine and lintuzumab versus low-dose cytarabine and placebo in older adults with untreated acute myeloid leukemia. Haematologica. 2013;98(1):119–128.
   PubMed Web of Science ®Google Scholar
• Lee E, Koh Y, Hong J, Eom HS, Yoon SS. Recent Clinical Update of Acute Myeloid Leukemia: focus on Epigenetic Therapies. J Korean Med Sci. 2021;36(13):e85.
   PubMed Web of Science ®Google Scholar
• Chen B, Huang S. Circular RNA: an emerging non-coding RNA as a regulator and biomarker in cancer. Cancer Lett. 2018;418:41–50.
   PubMed Web of Science ®Google Scholar
• Zhao X, Cai Y, Xu J. Circular RNAs: biogenesis, Mechanism, and Function in Human Cancers. Int J Mol Sci. 2019;20:16.
   Web of Science ®Google Scholar
• Chen Y, Li C, Tan C, Liu X. Circular RNAs: a new frontier in the study of human diseases. J Med Genet. 2016;53:359–365. doi:10.1136/med
   PubMed Web of Science ®Google Scholar
• Shang J, Chen WM, Liu S, et al. CircPAN3 contributes to drug resistance in acute myeloid leukemia through the regulation of autophagy. Leuk Res. 2019;85:106198. doi:10.1016/j.leukres.2019.106198
   PubMed Web of Science ®Google Scholar
• Che H, Ding H, Jia X. circ_0080145 Enhances imatinib resistance of chronic myeloid leukemia by regulating miR-326/PPFIA1 axis. Cancer Biother Radiopharm. 2020;1:548.
   Google Scholar
• Liu Z, Wang Q, Wang X, Xu Z, Wei X, Li J. Circular RNA cIARS regulates ferroptosis in HCC cells through interacting with RNA binding protein ALKBH5. Cell Death Discov. 2020;6:72. doi:10.1038/s41420-020-00306-x
   PubMed Web of Science ®Google Scholar
• Chen YG, Chen R, Ahmad S, et al. N6-methyladenosine modification controls circular RNA immunity. Mol Cell. 2019;76:96–109.
   PubMed Web of Science ®Google Scholar
• Cheng Y, Su Y, Wang S, et al. Identification of circRNA-lncRNA-miRNA-mRNA Competitive Endogenous RNA Network as Novel Prognostic Markers for Acute Myeloid Leukemia. Genes. 2020;11(8):548.
   PubMed Web of Science ®Google Scholar
• Guo S, Li B, Chen Y, et al. Hsa_circ_0012152 and Hsa_circ_0001857 Accurately Discriminate Acute Lymphoblastic Leukemia from Acute Myeloid Leukemia. Front Oncol. 2020;10:1655.
   PubMed Web of Science ®Google Scholar
• Zhou J, Zhou LY, Tang X, et al. Circ-Foxo3 is positively associated with the Foxo3 gene and leads to a better prognosis in acute myeloid leukemia patients. BMC Cancer. 2019;19(1):93.
   PubMed Web of Science ®Google Scholar
• Ding Y, Dong Y, Lu H, et al. Circular RNA profile of acute myeloid leukemia indicates circular RNA annexin A2 as a potential biomarker and therapeutic target for acute myeloid leukemia. Am J Transl Res. 2020;12(5):1683–1699.
   PubMed Web of Science ®Google Scholar
• Huang D, Yang Y, Sun J, et al. Annexin A2- S100A10 heterotetramer is upregulated by PML/RARalpha fusion protein and promotes plasminogen-dependent fibrinolysis and matrix invasion in acute promyelocytic leukemia. Front Med. 2017;11:410–422.
   PubMed Web of Science ®Google Scholar
• Ganesan S, Palani HK, Lakshmanan V, et al. Stromal cells downregulate miR-23a-5p to activate protective autophagy in acute myeloid leukemia. Cell Death Dis. 2019;10:736.
   PubMed Web of Science ®Google Scholar
• Seo M, Kim SM, Woo EY, et al. Stemness-attenuating miR-503-3p as a paracrine factor to regulate the growth of cancer stem cells. Stem Cells Int. 2018;2018:4851949.
   PubMed Web of Science ®Google Scholar
• Niu Y, Yang X, Chen Y, et al. Distinct prognostic values of Annexin family members expression in acute myeloid leukemia. Clin Transl Oncol. 2019;21(9):1186–1196.
   PubMed Web of Science ®Google Scholar
• Bock S, Murgueitio MS, Wolber G, et al. Acute myeloid leukemia-derived Langerhans-like cells enhance Th1 polarization upon TLR2 engagement. Pharmacol Res. 2016;105:44–53.
   PubMed Web of Science ®Google Scholar
• Brunetti L, Gundry MC, Goodell MA. New insights into the biology of acute myeloid leukemia with mutated NPM1. Int J Hematol. 2019;110(2):150–160. doi:10.1007/s12185-018-02578-7
   PubMed Web of Science ®Google Scholar
• Papaioannou D, Volinia S, Nicolet D, et al. Clinical and functional significance of circular RNAs in cytogenetically normal AML. Blood Adv. 2020;4(2):239–251. doi:10.1182/bloodadvances.2019000568
   PubMed Web of Science ®Google Scholar
• Tang X, Ren H, Guo M, Qian J, Yang Y, Gu C. Review on circular RNAs and new insights into their roles in cancer. Comput Struct Biotechnol J. 2021;19:910–928. doi:10.1016/j.csbj.2021.01.018
   PubMed Web of Science ®Google Scholar